PF3 activity in normal subjects and beta-thalassemia trait

Area of Science:

• Hematology
• Biochemistry
• Coagulation Science

Background:

• Platelet Factor 3 (PF3) is crucial for coagulation, released upon platelet activation.
• Erythrocyte membranes possess PF3-like activity, potentially influencing platelet activation in certain disorders.
• Measuring PF3 activity in plasma was historically challenging.

Purpose of the Study:

• To investigate the impact of abnormal erythrocytes on platelet activation.
• To assess the role of erythrocyte membrane fractions in PF3 activity.
• To evaluate changes in PF3 activity over time using a novel chromogenic assay.

Main Methods:

• Utilized a sensitive chromogenic test to quantify PF3 activity in whole blood and platelet-rich plasma.
• Monitored PF3 activity and platelet counts in normal subjects over 90 minutes.
• Compared PF3 activity and platelet counts in beta-thalassemia trait subjects with normal controls.

Main Results:

• Normal whole blood showed a significant increase in PF3 activity after 90 minutes, without significant platelet count changes.
• Beta-thalassemia trait whole blood exhibited significantly higher PF3 activity at 90 minutes compared to normal subjects.
• PF3 activity did not increase in platelet-rich plasma from beta-thalassemia trait subjects, and platelet counts significantly decreased.

Conclusions:

• The elevated PF3 activity observed in beta-thalassemia trait is primarily attributed to the abnormal erythrocytes.
• Abnormal erythrocytes contribute to platelet activation through enhanced PF3-like activity.
• The chromogenic assay effectively detects time-dependent changes in PF3 activity influenced by erythrocyte abnormalities.